Bumrungrad Hospital Pub Co (BH) Earnings: 2Q Net Income Exceeds Estimates with EPS Surpassing Forecasts

Bumrungrad Hospital Pub Co on Smartkarma

Analyst coverage on Bumrungrad Hospital Pub Co by top independent analysts on Smartkarma reveals positive sentiments towards the company’s recent financial performance. Tina Banerjee‘s report titled “Bumrungrad Hospital (BH TB): Record High Margins in 1Q24; Reasonable Growth in Foreign Patients” highlights the company’s achievement of record high margins in the first quarter of 2024, driven by tight cost control. The company saw significant growth in revenue and profits, with international patient revenue also showing a positive trend.

In another report by Tina Banerjee, “Bumrungrad Hospital (BH TB): Record High Performance in 2023; Middle-East Performance Recovers,” the analyst notes a remarkable 23% revenue growth in 2023, attributed to a diverse patient base including international, expat, and Thai patients. Margins expanded due to various factors, such as increasing revenue from high-margin international patients and effective cost management strategies. Despite concerns about unrest in the Middle-East, the company managed to improve revenue from this region in the latter half of 2023.

A look at Bumrungrad Hospital Pub Co Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, Bumrungrad Hospital Pub Co has a promising long-term outlook. With high scores in Growth, Resilience, and Momentum, the company seems well-positioned for future success. The Growth score of 5 indicates strong potential for expanding its operations and increasing market share. Furthermore, the Resilience and Momentum scores of 5 suggest that the company has the ability to withstand challenges and maintain positive performance momentum.

Bumrungrad Hospital Pub Co, the owner and operator of Bumrungrad Hospital in Bangkok, is well-equipped with a capacity of 554 beds for inpatients and about 125 clinic examination suites. The hospital provides international standard medical care and can cater to a significant volume of outpatients daily. Overall, with its solid Growth, Resilience, and Momentum scores, Bumrungrad Hospital Pub Co appears to be in a favorable position for long-term growth and success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma